When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these ...

SCIENTISTS investigating Alzheimer’s disease have made a key breakthrough, identifying a key cellular process that drives ...

Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

Even as new drugs come to market, further study appears to point to infections as a possible cause for the debilitating ...

Although we don't know a lot about the causes of Alzheimer's disease, the following conditions may raise your risk.

Your loved one's treatments will depend on the type they have. Many older people fear that they have Alzheimer's disease because they can't find their eyeglasses or remember someone's name.

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...

The daily medication, called hydromethylthionine mesylate (HMTM), was developed by British firm TauRX in Aberdeen ...

Shares of Axsome Therapeutics dropped Monday on mixed test results for its Alzheimer's disease agitation treatment.